Prion diseases are uncommon fatal neurodegenerative disorders which have gained scientific and public importance as a result of major advances in the understanding of the nature of the causative agent, and the emergence of new forms of these diseases in both animals and man. The transmissible agent
The complement system in prion diseases
β Scribed by Neil A Mabbott
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 642 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0952-7915
No coin nor oath required. For personal study only.
β¦ Synopsis
The complement system is an essential component of the innate immune system that aids the recognition and destruction of pathogens. Despite the potent cytolytic activity of this system, some pathogens have turned interactions with complement to their advantage. Transmissible spongiform encephalopathies (TSEs), or prion diseases, also seem to use the complement system to facilitate target cell infection in lymphoid tissues. TSEs are associated with the accumulation of disease-specific prion protein in the brain, which is accompanied by progressive neurodegeneration. Unregulated activation of complement can cause host tissue damage, as observed in some neurodegenerative disorders, and active complement components have been detected in the brains of hosts with TSEs. Whether complement inhibitors will be useful to treat TSEs remains to be determined.
π SIMILAR VOLUMES
## Abstract Alzheimer's disease (AD) and prion disease are characterized neuropathologically by extracellular deposits of AΞ² and PrP amyloid fibrils, respectively. In both disorders, these cerebral amyloid deposits are coβlocalized with a broad variety of inflammationβrelated proteins (complement f